8 projets européens trouvés
Recherche sur 125080 projets européens
TERMINÉ
Ex vivo Re-vascularization in Porcine Liver Bioengineering - A Critical First Step Towards Effective Transplantation of Bioengineered Livers (Liver Bioengineering)
Date du début: 1 août 2015, Date de fin: 31 juil. 2017,
Liver transplantation is currently the only proven therapy to extend life of patients with terminal liver disease. Organ bioengineering and regenerative medicine are promising new technologies that can help reduce the burden of liver shortage by increasing the number of organs available for transplantation. However, current bioengineered livers lack a functional vascular network that can readily a ...
Voir le projet
1
Participant partenaire
TERMINÉ
Identification and validation of cerebral KCa3.1/KCa2.3 potassium channels a drug tragets for the prevention and treatment of cerebral ischemia associated with diabetes and Alzheimers disease (BrainIK)
Date du début: 1 oct. 2012, Date de fin: 30 sept. 2016,
The objectives of the project are to identify and evaluate potassium channels of the KCa3.1/KCa2.X type as novel drug targets for the prevention and treatment of cerebrovascular ischemia and neuroprotection in metabolic disease and neurodegenerative disorders associated with vascular pathologies, as a new pathophysiological concept and treatment strategy.To reach these aims, the proponent employs ...
Voir le projet
1
Participant partenaire
TERMINÉ
Apolipoprotein E gene in the Metabolic Syndrome (APOMET)
Date du début: 1 mai 2012, Date de fin: 30 avr. 2016,
"Metabolic Syndrome (MetS) is closely linked to disturbances in lipid and glucose metabolism and increases the risk of developing cardiovascular disease and diabetes. One-fourth of the adult European population has the MetS and a further increase is anticipated because a greater prevalence of obesity in the future. Apolipoprotein E (APOE) associates with lipoproteins and mediates theirmetabolism. ...
Voir le projet
1
Participant partenaire
TERMINÉ
Red Transfronteriza de Investigación Biomédica de los Pirineos- Establecimiento de una Red de colaboración estable entre Centros de Investigación Biomédica en el espacio Pirineos (BIOMED-PIRINEOS)
Date du début: 31 mai 2012, Date de fin: 29 nov. 2014,
...Servet (líder) ,Institute National de la Santé et de la Recherche Médicale (INSERM) de Midi Pyrénées Limousin,Instituto Aragonés de Ciencias de la Salud (IACS), Université Paul Sabatier de Toulouse, Centre Hospitalier Universitaire de Toulouse (CHU), Fundación Vasca de Innovación e Investigación Sanitarias (BIOEF), Centro de Investigación Biomédica de La Rioja (CIBIR) e Instituto de Investigación ...
Voir le projet
8
Participants partenaires
TERMINÉ
MITOCHONDRIAL RESPIRATORY CHAIN ASSEMBLY (MRCA)
Date du début: 10 avr. 2009, Date de fin: 8 juin 2014,
"Oxidative phosphorylation (OXPHOS) is the metabolic process that provides most of the energy usable by the cells. OXPHOS couples two sets of reactions, respiration and ATP synthesis. Respiration consists in the sequential transfer of electrons carried out by the mitochondrial respiratory chain (MRC) complexes I (CI), II (CII), III (CIII), and IV (CIV). The proton gradient generated during respira ...
Voir le projet
2
Participants partenaires
TERMINÉ
European Collaboration for Healthcare Optimization (ECHO)
Date du début: 1 mars 2010, Date de fin: 28 févr. 2014,
"ECHO, European Collaboration for Healthcare Optimization, gathers the interests for Healthcare Performance Measurement of different Academic and Research Institutions from six European countries and an International Body for Healthcare Policy Analysis. Designed as a 48 months project, it has been conceived as a “pilot study” based on available administrative databases. It aims at describing the a ...
Voir le projet
8
Participants partenaires
TERMINÉ
Building a cooperative strategy between Europe and Mediterranean Countries for upgrading tuberculosis research and control (EUMEDNETvsTB)
Date du début: 1 mars 2010, Date de fin: 28 févr. 2013,
Tuberculosis (TB) accounts amongst the most deadly infectious diseases worldwide. Despite the availability of a vaccine and effective drugs, Mycobacterium tuberculosis, the etiologic agent of TB, still defies the humanity. An alarming increase in drug resistance and emergence of outbreaks has made it urgent the need for increased surveillance and control. With its structured global geographical di ...
Voir le projet
7
Participants partenaires
TERMINÉ
Chip Architectures by Joint Associated Labs for European Diagnostics (CAJAL4EU)
Date du début: 1 mars 2010, Date de fin: 1 févr. 2013,
The main objective of the ENIAC JU project CAJAL4EU is to develop miniaturised biosensor technology platforms enabling diagnostic test manufacturers to build multi-parameter in-vitro test applications rapidly in a robust, user-friendly and cost-effective way. They will involve nanoelectronic-based transducers with chemical sensing capabilities providing the interface with the clinical samples. In ...
Voir le projet